TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18567678

Group type: EXPERIMENTAL
Intervention: mct/lct-propofol with lidocaine 10 mg/ml
Number of subjects: 160

Group type: COMPARATOR
Intervention: lct-propofol with saline
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: lct-propofol with lidocaine 10 mg/ml
Number of subjects: 160

Group type: COMPARATOR
Intervention: mct/lct-propofol with saline
Number of subjects: 160
Study: 16422890

Group type: EXPERIMENTAL
Intervention: Testosterone patch
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 28

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 28
Study: 12424331

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (including one can of V-8 juice daily) for 2 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 10076483

Group type: EXPERIMENTAL
Intervention: Mass media-led smoking cessation campaign (including television shows, a television clinic, a quit line, local group programs, and a comprehensive publicity campaign)
Number of subjects: 1338

Group type: EXPERIMENTAL
Intervention: Mass media-led smoking cessation campaign
Number of subjects: 1338

Group type: COMPARATOR
Intervention: Control group (nonpretested baseline smokers)
Number of subjects: 1338
Study: 7719761

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (3 mg/kg in saline)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 6
Study: 2035860

Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine (0.25% mixed with 10% dextrose)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Isobaric bupivacaine (0.25% mixed with 0.9% NaCl)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Hypobaric bupivacaine (0.25% mixed with distilled water)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine (0.25%)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Isobaric bupivacaine (0.25%)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Hypobaric bupivacaine (0.25%)
Number of subjects: 45
Study: 31145226

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) ketorolac
Number of subjects: 224
Study: 31418043

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation 5 times/week for 4 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 39
Study: 27763895

Group type: EXPERIMENTAL
Intervention: Low urine output target of 0.2 mL/kg/h
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard urine output target of 0.5 mL/kg/h
Number of subjects: 40
Study: 26472590

Group type: EXPERIMENTAL
Intervention: Acupuncture (AG)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EG)
Number of subjects: 66
Study: 24565620

Group type: EXPERIMENTAL
Intervention: Peer support group meetings and mp3 peer-recorded asthma messages
Number of subjects: 68

Group type: COMPARATOR
Intervention: Attention control group (ATG) with weekly meetings with a research assistant and mp3 physician-recorded asthma messages
Number of subjects: 68
Study: 21482925

Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 19735398

Group type: EXPERIMENTAL
Intervention: Midazolam 30 microg x kg(‐1) with cotton blanket
Number of subjects: 120

Group type: COMPARATOR
Intervention: Forced-air warmer
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Forced-air warmer with midazolam 30 microg x kg(‐1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cotton blanket with saline injection
Number of subjects: 120
Study: 17722829

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for 60-90 sessions after rehabilitation training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rehabilitation training including ABA training, Conductive Education Approach, and sensory integration training for about 90 sessions
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rehabilitation training
Number of subjects: 40
Study: 15161075

Group type: EXPERIMENTAL
Intervention: Nasal vaccination with cholera toxin B subunit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rectal vaccination with cholera toxin B subunit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrajejunal vaccination with cholera toxin B subunit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral vaccination with cholera toxin B subunit
Number of subjects: 0
Study: 11484451

Group type: EXPERIMENTAL
Intervention: Josamycin 50 mg.kg‐1.day‐1 b.i.d for 5 days
Number of subjects: 325

Group type: COMPARATOR
Intervention: Penicillin 50,000 to 100,000 IU/day t.i.d for 10 days
Number of subjects: 325
Study: 9656557

Group type: EXPERIMENTAL
Intervention: Single nightly prophylactic dose of an antibiotic
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Single nightly dose of oxybutinin (or divided in 2-4 doses)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Single nightly prophylactic dose of an antibiotic and oxybutinin as in group II
Number of subjects: 150
Study: 7914462

Group type: EXPERIMENTAL
Intervention: Adjunctive bilateral electroconvulsive therapy (ECT)
Number of subjects: 35
Study: 2494016

Group type: EXPERIMENTAL
Intervention: Ambient temperature of 33 degrees C
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ambient temperature of 23 degrees C
Number of subjects: 6
Study: 4457275

Group type: EXPERIMENTAL
Intervention: Sodium picosulphate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standardised senna
Number of subjects: 50
Study: 31475497

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fuyang-pot warming
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination of Fuyang-pot warming and EA
Number of subjects: 90
Study: 29074352

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA): bolus of 10mg/kg at induction followed by infusion of 1mg/kg/h intraoperatively and for 24h postoperatively
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 131
Study: 26055226

Group type: EXPERIMENTAL
Intervention: Custom-made hydrogel silicone contact lens (Kerasoft-IC CL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sector management control (SMC) designs
Number of subjects: 30
Study: 23878021

Group type: EXPERIMENTAL
Intervention: Intended harms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unintended harms
Number of subjects: 0
Study: 21668442

Group type: EXPERIMENTAL
Intervention: Steroid therapy
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Age at onset of spasms
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Lead time to treatment
Number of subjects: 77
Study: 19504550

Group type: EXPERIMENTAL
Intervention: Radiofrequency surgery of the soft palate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (insertion of applicator without energy delivery)
Number of subjects: 32
Study: 16307711

Group type: EXPERIMENTAL
Intervention: Concurrent task of randomly generating months of the year aloud (dual-task condition)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Articulatory suppression by repeating the word 'December' (dual-task condition)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Single-task condition (baseline)
Number of subjects: 42
Study: 12727575

Group type: EXPERIMENTAL
Intervention: Presence of a third heart sound (S(3))
Number of subjects: 4102

Group type: EXPERIMENTAL
Intervention: Elevated jugular venous pressure
Number of subjects: 4102

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 4102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4102
Study: 11256058

Group type: EXPERIMENTAL
Intervention: Patients identified as distressed by GP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients identified as not distressed by GP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Distressed patients not recognized as such
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personality measures (emotional dependency and health locus of control)
Number of subjects: 0
Study: 9257429

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT: 5‐fluorouracil and levamisole)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Follow-up after radical surgery (Control)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT)
Number of subjects: 95
Study: 8224687

Group type: EXPERIMENTAL
Intervention: Main pancreatic duct stent
Number of subjects: 98

Group type: COMPARATOR
Intervention: No stent
Number of subjects: 98
Study: 3948545

Group type: EXPERIMENTAL
Intervention: Caffeine (7.2 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Aminophylline (200 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Caffeine (various doses: 0.2, 2.5, 5.6, 7.2 mg/kg)
Number of subjects: 9
Study: 31607352

Group type: EXPERIMENTAL
Intervention: Qigong exercise (5-week intervention in RCT1)
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Qigong exercise (8-week intervention in RCT2)
Number of subjects: 287
Study: 28001492

Group type: EXPERIMENTAL
Intervention: Proximal temporal framing
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Distal temporal framing
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Proximal temporal framing (Amazon Mechanical Turk data)
Number of subjects: 262

Group type: COMPARATOR
Intervention: No messages
Number of subjects: 262
Study: 26354054

Group type: EXPERIMENTAL
Intervention: Udenafil and aceclofenac
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 23724570

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study: 21422367

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF) with surgeon experience >30 LNFs (LNFII)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Conventional Nissen fundoplication (CNF)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Laparoscopic Nissen fundoplication (LNF) with surgeon experience >5 LNFs (LNFI)
Number of subjects: 288
Study: 18840257

Group type: EXPERIMENTAL
Intervention: Baclofen (0, 40, and 80 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Baclofen alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Baclofen in combination with alcohol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 16505224

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg for 4 months)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: COMPARATOR
Intervention: Nondiabetic plaques
Number of subjects: 46
Study: 15291903

Group type: EXPERIMENTAL
Intervention: Active treatment group (acupuncture and Chinese herbal medicine)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (acupuncture applied to non-acupuncture points and non-specific Chinese herbal formula)
Number of subjects: 52
Study: 11815726

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogen (CEE) and 2.5 mg medroxyprogesterone acetate (MPA) every other day
Number of subjects: 68

Group type: COMPARATOR
Intervention: 0.625 mg CEE and 2.5 mg MPA every day
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Low estradiol group (<15 pg/ml)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Middle estradiol group (>=15 and <25 pg/ml)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: High estradiol group (>=25 pg/ml)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Low estradiol group
Number of subjects: 68
Study: 9403204

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (Sandoglobulin) at a dose of 1 g/kg before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no immunoglobulin treatment)
Number of subjects: 60
Study: 8435693

Group type: EXPERIMENTAL
Intervention: Drug treatment (primarily antidepressants)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Cognitive and behaviour therapy
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Self-help treatment programme
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 181
Study: 3308992

Group type: EXPERIMENTAL
Intervention: Benson's Relaxation Technique (BRT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Attention-distraction control group (CA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rhythmic breathing exercise (RB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard control (CB)
Number of subjects: 40
Study: 29764000

Group type: EXPERIMENTAL
Intervention: Therapeutic clowning and video activities
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control group (no therapeutic clowning)
Number of subjects: 195
Study: 27382098

Group type: EXPERIMENTAL
Intervention: ECF plus cetuximab
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: IC plus cetuximab
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: FOLFOX plus cetuximab
Number of subjects: 245
Study: 24464746

Group type: EXPERIMENTAL
Intervention: Plasma galectin 3 (Gal‐3) measured using ELISA
Number of subjects: 924

Group type: COMPARATOR
Intervention: Control group (subjects alive and free of HF at the time of index case occurrence)
Number of subjects: 924
Study: 22210571

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 146
Study: 20608035

Group type: EXPERIMENTAL
Intervention: Combination of lascropuncture infrared radiation and manual therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Traditional treatment
Number of subjects: 120
Study: 18684311

Group type: EXPERIMENTAL
Intervention: High-dose KRG (9 g/day)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Low-dose KRG (4.5 g/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study: 16401158

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 85

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 85
Study: 11503980

Group type: EXPERIMENTAL
Intervention: Percutaneous repair
Number of subjects: 66

Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 66
Study: 9763721

Group type: EXPERIMENTAL
Intervention: AD + mefloquine
Number of subjects: 380

Group type: COMPARATOR
Intervention: AD + placebo
Number of subjects: 380
Study: 7918926

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29120040

Group type: EXPERIMENTAL
Intervention: Prostin 15M (15(S)15 methyl PGF2alpha) at a dose of 250 microg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no drugs for cervical dilatation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prostin 15M
Number of subjects: 0
Study: 31687984

Group type: EXPERIMENTAL
Intervention: Elastic resistance exercise training for 12 weeks
Number of subjects: 60
Study: 29896793

Group type: EXPERIMENTAL
Intervention: Outpatient medical services within 7 days postdischarge
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Laboratory services within 7 days postdischarge
Number of subjects: 497
Study: 28371338

Group type: EXPERIMENTAL
Intervention: 10 g freeze‐dried nasturtium leaf material
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 15
Study: 23571143

Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasound (LUS)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Transabdominal ultrasound (TAU)
Number of subjects: 253
Study: 21735688

Group type: EXPERIMENTAL
Intervention: Transdermal 17beta-estradiol (Oesclim 50) combined with oral norethisterone 2.5 mg daily (Primolut-Nor)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Oral 2 mg 17beta-estradiol combined with oral 1 mg daily norethisterone (Kliogest)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No treatment (Control Group C)
Number of subjects: 39
Study: 19884716

Group type: EXPERIMENTAL
Intervention: CAF+ADM+EMD
Number of subjects: 15

Group type: COMPARATOR
Intervention: CAF+ADM
Number of subjects: 15
Study: 16720445

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS) 200 microg once daily (QD)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS) 200 microg QD
Number of subjects: 298
Study: 15176158

Group type: EXPERIMENTAL
Intervention: Azelaic acid 15% gel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intense pulsed light therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose doxycycline hyclate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide/clindamycin gel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New formulations of metronidazole and sulfacetamide 10%/sulfur 5%
Number of subjects: 0
Study: 11753747

Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitors (SSRIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychostimulants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional tricyclic antidepressants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 9274080

Group type: EXPERIMENTAL
Intervention: Implant-retained mandibular overdentures
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional treatments
Number of subjects: 90

Group type: COMPARATOR
Intervention: All treatment modalities
Number of subjects: 90
Study: 8175848

Group type: EXPERIMENTAL
Intervention: Proximal femoral prosthesis without cement (group 1)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Proximal femoral prosthesis with cement (group 2)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Modified femoral prosthesis without hydroxyapatite coating (group 3)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Modified femoral prosthesis with hydroxyapatite coating (group 4)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Migration test applied to all groups
Number of subjects: 4
Study: 3052169

Group type: EXPERIMENTAL
Intervention: Pentazocine
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 82

Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 82
Study: 31965406

Group type: EXPERIMENTAL
Intervention: Medical Outcomes Study Sleep Questionnaire (MOSSQ)
Number of subjects: 7604
Study: 31222540

Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone intravenously on the induction of anaesthesia
Number of subjects: 60
Study: 28497569

Group type: EXPERIMENTAL
Intervention: AVP-825 (22 mg sumatriptan nasal powder)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Oral Sumatriptan (100 mg)
Number of subjects: 185
Study: 25567657

Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg orally for 8 days + Ondansetron 8 mg intravenously 30 min before chemotherapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Ondansetron 8 mg intravenously 30 min before chemotherapy
Number of subjects: 84
Study: 23374650

Group type: EXPERIMENTAL
Intervention: Biodegradable polymer biolimus-eluting stent (Nobori, Terumo, Tokyo, Japan)
Number of subjects: 2707

Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stent (Xience V or Prime, Abbott Vascular, Santa Clara, CA, USA, or Promus, Boston Scientific, Natick, MA, USA)
Number of subjects: 2707
Study: 22005587

Group type: EXPERIMENTAL
Intervention: CBT plus low-energy-density diet (CBT+ED)
Number of subjects: 50

Group type: COMPARATOR
Intervention: CBT plus General Nutrition counseling (CBT+GN)
Number of subjects: 50
Study: 19480091

Group type: EXPERIMENTAL
Intervention: Raltegravir added to an optimised antiretroviral regimen
Number of subjects: 40

Group type: COMPARATOR
Intervention: Optimised regimen plus placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Raltegravir/tenofovir/lamivudine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Efavirenz/tenofovir/lamivudine
Number of subjects: 40
Study: 22422607

Group type: EXPERIMENTAL
Intervention: DEB plus BMS
Number of subjects: 117

Group type: COMPARATOR
Intervention: BMS
Number of subjects: 117

Group type: COMPARATOR
Intervention: Paclitaxel DES
Number of subjects: 117
Study: 15981145

Group type: EXPERIMENTAL
Intervention: Teaching intervention (specific teaching technique not detailed)
Number of subjects: 36
Study: 12859101

Group type: COMPARATOR
Intervention: Starting on the first day of the period (n = 80)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Starting on the seventh day of the period (n = 80)
Number of subjects: 160
Study: 9855810

Group type: EXPERIMENTAL
Intervention: New teaching aid for charting methods
Number of subjects: 58

Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 58
Study: 7611577

Group type: EXPERIMENTAL
Intervention: Paracetamol (250-500 mg rectally after intubation)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.5% two drops on conjunctiva after intubation)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (rectal paracetamol after operation before extubation)
Number of subjects: 50
Study: 2698435

Group type: EXPERIMENTAL
Intervention: roxithromycin (RXT) 300 mg/day orally for an average of 9 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: antibiotic/s (ATB) based on identified microorganisms, mean duration of treatment 12 days
Number of subjects: 48
Study: 25567

Group type: EXPERIMENTAL
Intervention: Racemic propranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dextrorotatory isomer of propranolol
Number of subjects: 0
Study: 31675299

Group type: EXPERIMENTAL
Intervention: Cruciate-Retaining (CR) implant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cruciate-Substituting (PS) implant
Number of subjects: 0
Study: 27160848

Group type: EXPERIMENTAL
Intervention: Office hysteroscopy before starting ART cycle
Number of subjects: 220

Group type: COMPARATOR
Intervention: No office hysteroscopy (control group)
Number of subjects: 220
Study: 26667110

Group type: EXPERIMENTAL
Intervention: Intervention group (n=81)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (n=79)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Intervention group (prepubescent children)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (prepubescent children)
Number of subjects: 160
Study: 23789453

Group type: EXPERIMENTAL
Intervention: Combined treatment including melatonin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy including hepatoprotectors
Number of subjects: 0